Select a community
All Communities
Home > Community Treatment Reports > Selegiline Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Selegiline Treatment Report

Brand Names: Zelapar, Eldepryl, Emsam

What is Selegiline? Selegiline is a Monoamine Oxidase (MAO) inhibitor. It is an antidepressant and anti-Parkinson's agent. When used in combination with levodopa containing drugs such as Sinemet it can improve their efficacy by slowing the breakdown of levodopa. The transdermal product is used to treat depression.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

246 patients in the community are taking or have taken Selegiline.

Top 10 (Show all)

Dosages

Based on the patients currently taking Selegiline.

Top 10 (Show all)

All (Show top 10)

  5mg as needed 6 mg/24 hr all the time (24/7) daily 0.1 mg daily 0.5 mg daily 1.25 mg daily 1.5 daily 1.5 mg daily 2.25 mg daily 2.5 mg daily 3 mg daily 5 mg daily 5 mg one time 6 mg/24 hr daily 9 mg/24 hr daily 10 mg daily 12 mg/24 hr daily 12 mg daily 15 mg daily 20 mg daily 40 mg daily 125 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 7 Number of Patients: 7 1 Number of Patients: 1 2 Number of Patients: 2 9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 18 Number of Patients: 18 1 Number of Patients: 1 33 Number of Patients: 33 1 Number of Patients: 1 3 Number of Patients: 3 4 Number of Patients: 4 70 Number of Patients: 70 2 Number of Patients: 2 1 Number of Patients: 1 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Selegiline or how long patients were taking Selegiline before stopping.

Currently Taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
2
7
14
26
32

Stopped Taking Selegiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
14
9
8
8
11
30
Why Patients Stopped Taking Selegiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 27 33% Did not seem to work: 33%
Doctor's advice 22 27% Doctor's advice: 27%
Other 20 24% Other: 24%
Side effects too severe 17 21% Side effects too severe: 21%
Personal research 7 9% Personal research: 9%
Expense 5 6% Expense: 6%
Course of treatment ended 2 2% Course of treatment ended: 2%
Not indicated 2 2% Not indicated: 2%

Patient Reported Evaluations

Results from 36 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 21% 4
Moderate 26% 5
Slight 26% 5
None 5% 1
Can't tell 21% 4

Treat Parkinson's

Side-effects (as an overall problem)

Severe 17% 6
Moderate 6% 2
Mild 14% 5
None 64% 23

Top reported side-effects include: trouble falling asleep, Dietary restrictions, Insomnia

Summary results are based on 36 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 36)

  • dixie pixie
    Sex: F
    Mouth/throat: mild
    Arms: mild
    Chest: mild
    Legs: mild
  • dixie pixie
  • by dixie pixie
    Apr 07, 2008
  • EfficacyCan't tell
  • Side-effectsNone
  • Treat Parkinson's

  • Dan McRight
    Sex: M
    Mouth/throat: none
    Arms: mild
    Chest: none
    Legs: none
  • Dan McRight
  • by Dan McRight
    Aug 20, 2008
  • EfficacySlight
  • Side-effectsNone
  • Treat Parkinson's
Advice/Tips
Discontinued 8/4/08

See all evaluation results for Selegiline

Report created on November 08, 2009.